Karl Thiel
speaker
144 appearances
3 recordings
1 series
first heard Oct 2025
last heard 2 Feb
Karl Thiel’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 3 in all, peaking in Feb 2026 with 1.
Appearances
Motley Fool Hidden Gems Investing · Biotech Beat NVIDIA in 2025. Can It Do It Again? · 2 Feb 2026
podcast
No se on se hyvänmakuinen Sanasol monivitamiinipore.
Yhessä lasillisessa on kato päivän vitamiinit.
Makuina on muun muassa appelsiinia.
Ja sitten fruitmix hedelmä.
This is a good old-fashioned product-slash-platform deal in the sector.
What Sedara does is, most directly, what Merck is buying right now is an influenza
drug that shouldn't be subject to year-to-year variation.
It's a different way of going after influenza.
You can see why that would be a relatively big deal.
There's a lot of flu shots given out every year.
Yeah.
I think it's interesting on a number of levels.
One is just that usually, M&A in the pharma sector is just dominated by oncology, and it still is.
But we've seen a lot more start going to these broader health issues around obesity and around, in this case, infectious disease, so influenza.
The other reason I think it's super interesting is just
that it came at a huge premium.
I'll say.
Yeah, $9.2 billion all-cash deal, 109% premium to where Sedar was trading before that.
I just think that that gets at continuing some mispricing in the sector.
You expect an M&A deal to come at some premium, but that's a pretty big one.
Showing 1–20 of 144 · page 1 of 8
Next →